Relevant financial disclosures: None
A recent real-world study from Virta Health found that individuals with type 2 diabetes who discontinued GLP-1 therapy while continuing a ketogenic or low-carb diet maintained their weight loss over 12 months, with more than 70% sustaining at least 5% weight loss
[PUBMED Abstract] Bartsch DK, Sina-Frey M, Lang S, et al.: CDKN2A germline mutations in familial pancreatic cancer
Label Transparency: Slimpic's disclosure of exact milligram dosages for the prebiotic fibers and the total weight of the probiotic blend, alongside a clean excipient profile, reinforces Slimpic's credibility as a transparent formula
Temporary dose adjustment is often the first management strategy for troublesome vomiting
The study was led by Dr Andres Acosta, a globally recognised expert in obesity research and co-founder of Phenomix, and was presented by Dr Thomas Fredrick